|
Cardiovascular Disorders Drug Development Pipeline Review, 2017 |
Mar 16 2017 |
432 |
Global |
$3,995.00 |
|
|
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market |
Mar 1 2017 |
197 |
Global |
$4,995.00 |
|
|
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design |
Mar 1 2017 |
117 |
Global |
$2,995.00 |
|
|
Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing |
Jan 24 2017 |
63 |
Global |
$2,995.00 |
|
|
Dry Eye Syndrome - US Drug Forecast and Market Analysis to 2024 |
Nov 5 2015 |
196 |
USA |
$4,995.00 |
|
|
Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2024 |
Nov 5 2015 |
194 |
India |
$4,995.00 |
|
|
Dry Eye Syndrome - Japan Drug Forecast and Market Analysis to 2024 |
Nov 5 2015 |
194 |
Japan |
$4,995.00 |
|
|
Dry Eye Syndrome - 5EU Drug Forecast and Market Analysis to 2024 |
Nov 5 2015 |
197 |
Europe |
$6,995.00 |
|
|
Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2024 |
Nov 5 2015 |
192 |
China |
$4,995.00 |
|
|
Dry Eye Syndrome - Current and Future Players |
Nov 5 2015 |
84 |
Global |
$2,995.00 |
|
|
Atopic Dermatitis - 5EU Drug Forecast and Market Analysis to 2024 |
Nov 3 2015 |
152 |
Europe |
$6,995.00 |
|
|
Atopic Dermatitis - US Drug Forecast and Market Analysis to 2024 |
Nov 3 2015 |
146 |
USA |
$4,995.00 |
|
|
Atopic Dermatitis - Current and Future Players |
Nov 3 2015 |
58 |
Global |
$2,995.00 |
|
|
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 |
Nov 3 2015 |
143 |
Japan |
$4,995.00 |
|
|
Multiple Myeloma - 5EU Drug Forecast and Market Analysis to 2023 |
Nov 1 2015 |
175 |
Europe |
$6,995.00 |
|
|
Multiple Myeloma - Japan Drug Forecast and Market Analysis to 2023 |
Nov 1 2015 |
162 |
Japan |
$4,995.00 |
|
|
Multiple Myeloma - Current and Future Players |
Nov 1 2015 |
83 |
Global |
$2,995.00 |
|
|
Multiple Myeloma - China Drug Forecast and Market Analysis to 2023 |
Nov 1 2015 |
161 |
China |
$4,995.00 |
|
|
Multiple Myeloma - US Drug Forecast and Market Analysis to 2023 |
Nov 1 2015 |
164 |
USA |
$4,995.00 |
|
|
Opioids Overview to 2021 - An Assessment of Pain Management and Dependence |
Aug 10 2015 |
110 |
Global |
$2,995.00 |
|
